The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study

Patients with the genetic blistering skin condition epidermolysis bullosa (EB) report severe pain as a consequence of skin and mucous membrane lesions including blisters, wounds, and scars. Adequate symptom alleviation is not often achieved using conventional pharmacologic interventions. Finding nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Schräder, Nicholas H. B., Duipmans, José C., Renken, Remco J., Sörös, Peter, Vermeulen, Karin M., Bolling, Maria C., Wolff, André P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744305/
https://www.ncbi.nlm.nih.gov/pubmed/36508401
http://dx.doi.org/10.1371/journal.pone.0277512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744305/
https://www.ncbi.nlm.nih.gov/pubmed/36508401
http://dx.doi.org/10.1371/journal.pone.0277512

Ejemplares similares